Company
SINOVAC at Glance
Our History
Social Responsibilities
Innovation
Platform
Pipeline
Scientific Achievements
Partners
— Research Institute
— Universities
— Medical Institutions
— Companies
Products
Vaccines
International Business
Quality Management System
Product Consultation
Adverse Event Report
News
Press Releases
Updates and Statements
Media Asset Library
Investors
Corporate Governance
Financial Reports
SEC Filings
Careers
Our Talent
中文
EN
Contact Us
Company
SINOVAC at Glance
Our History
Social Responsibilities
News
Press Releases
Updates and Statements
Media Asset Library
— Logo
— Vaccines
Innovation
Platform
Pipeline
Scientific Achievements
Partners
— Research Institute
— Universities
— Medical Institutions
— Companies
Products
Vaccines
International Business
Quality Management System
Product Consultation
Adverse Event Report
Investors
Corporate Governance
— Board of Directors
— Management
Financial Reports
— YEAR 2024
— YEAR 2023
— YEAR 2021
— YEAR 2022
— YEAR 2020
— YEAR 2019
— YEAR 2018
— YEAR 2017
— YEAR 2016
— YEAR 2015
— YEAR 2014
— YEAR 2013
— YEAR 2012
— YEAR 2011
— YEAR 2010
— YEAR 2009
— YEAR 2008
— YEAR 2007
— YEAR 2006
— YEAR 2005
— YEAR 2004
— YEAR 2003
SEC Filings
— YEAR 2024
— YEAR 2023
— YEAR 2022
— YEAR 2021
— YEAR 2020
— YEAR 2019
— YEAR 2018
— YEAR 2017
— YEAR 2016
— YEAR 2015
— YEAR 2014
— YEAR 2013
— YEAR 2012
— YEAR 2011
— YEAR 2010
— YEAR 2009
Careers
Our Talent
Contact Us
联系我们
当前地点：
EN
选择地点：
中文
EN
Home
Company
SINOVAC at Glance
Our History
Social Responsibilities
News
Press Releases
Updates and Statements
Media Asset Library
Innovation
Platform
Pipeline
Scientific Achievements
Partners
Products
Vaccines
International Business
Quality Management System
Product Consultation
Adverse Event Report
Investors
Corporate Governance
Financial Reports
SEC Filings
Careers
Our Talent
Contact Us
中文
EN
Press Releases
ALL YEAR
All
YEAR 2024
YEAR 2023
YEAR 2022
YEAR 2021
YEAR 2020
YEAR 2019
YEAR 2018
YEAR 2017
YEAR 2016
YEAR 2015
YEAR 2014
YEAR 2013
YEAR 2012
YEAR 2011
YEAR 2010
YEAR 2009
YEAR 2008
YEAR 2007
YEAR 2006
YEAR 2005
2005/11/15
Sinovac Passes China’s Ministry of Science and Technology “Pandemic Influenza Vaccine R&D Project” Examination
2005/10/27
Sinovac Receives GMP Certification for its Seasonal Influenza Vaccine, AnFlu
2005/09/21
Sinovac to present at the UBS Global Life Sciences Conference and Announces Additional Funding
2005/09/12
Sinovac Biotech Ltd. Receives Flu Vaccine Production License from Chinese FDA
2005/09/12
WHO Meeting Held to Review the Results of Sinovac SARS Vaccine Phase I Trial and Discuss Phase II Protocols
2005/09/12
China’s new Vaccine Distribution System, and its Impact on Sinovac Biotech Ltd.
2005/09/12
Sinovac Biotech Ltd. Announces First Sales of its Proprietary Combined Hepatitis A&B Vaccine, BiliveTM
2005/09/12
Sinovac Biotech Ltd. Retains Segue Ventures, LLC for Investor Relations and Public Relations
2005/09/12
SINOVAC BIOTECH LTD. REPORTS 2004 SALES GROWTH OF 127 %
2005/09/12
Sinovac Biotech Ltd., and LG Life Sciences, Ltd. Announce their Letter of Intent for Collaboration in Global Marketing and Vaccine Supply
2005/09/12
SINOVAC BIOTECH LTD. ANNOUNCES THAT IT HAS LAUNCHED THE MARKETING OF ITSPROPRIETARY COMBINED HEPATITIS A&B VACCINE, BILIVE™
2005/09/12
SINOVAC BIOTECH LTD. ANOUNCES THAT IT HAS RECEIVED THE NEW DRUG CERTIFICATE FROM THE CHINESE GOVERNMENT FOR ITS SPLIT FLU VACCINE
2005/09/12
Sinovac Biotech Ltd.: Updates on its Avian Influenza Vaccine Development
2005/09/12
Sinovac Biotech Ltd. Announces Final Approval by the Chinese FDA (SFDA) for Bilive"TM", its Proprietary Combined Hepatitis A&B Vaccine
2005/09/12
SINOVAC BIOTECH LTD. LISTED ON HALTER USX CHINA INDEX
Previous page
1...
18
19
20
21
22
23
24
Next page
Go to No.
© SINOVAC All rights reserved
EN
